Fluoride as an inducible DNA cross-linking agent for new antitumor prodrug

Jun Wu1, Rong Huang, Tianlu Wang

  • 1College of Chemistry and Molecular Sciences, Key Laboratory of Biomedical Polymers of Ministry of Education, State Key Laboratory of Virology, Wuhan University, Hubei, Wuhan 430072, PR of China.

Insights

Two novel compounds activate to form DNA alkylating nitrogen mustards. This DNA damage leads to cell death, offering potential as antitumor prodrugs.

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Nitrogen mustards are potent DNA alkylating agents with established anticancer activity.
  • Prodrug strategies aim to improve drug delivery and reduce systemic toxicity.
  • Fluoride-mediated activation offers a novel approach for prodrug design.

Purpose of the Study:

  • To synthesize and characterize two new small compounds as potential prodrugs.
  • To investigate the fluoride-mediated self-rearrangement mechanism of these compounds.
  • To evaluate the DNA alkylating potential and cytotoxic effects of the activated compounds.

Main Methods:

  • Chemical synthesis of novel small compounds.
  • Nuclear magnetic resonance (NMR) and mass spectrometry for structural elucidation.
  • In vitro assays to assess fluoride-mediated activation and DNA alkylation.
  • Cell viability assays (e.g., MTT) to determine cytotoxicity in cancer cell lines.

Main Results:

  • Two new compounds were successfully synthesized and characterized.
  • Fluoride ions triggered a self-rearrangement process in the compounds.
  • The rearrangement yielded an active DNA alkylating nitrogen mustard species.
  • The activated agent induced significant DNA damage and subsequent cell death in tested cancer cells.

Conclusions:

  • The novel compounds function as effective prodrugs, releasing active nitrogen mustards upon fluoride exposure.
  • These findings highlight the potential of fluoride-mediated activation for developing targeted anticancer therapies.
  • Further investigation is warranted to explore their therapeutic efficacy and safety profile in vivo.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
FISH - Fluorescent In-situ Hybridization02:07

FISH - Fluorescent In-situ Hybridization

Fluorescence in situ hybridization, or FISH, was developed in the early 1980s and has quickly become one of the most widely used techniques in cytogenetics. Labeled probes are used to bind complementary DNA or RNA sequences on a chromosome or in a region within a cell. Earlier, the probes could only be obtained by cloning or reverse transcription of a DNA template. Currently, the probe oligonucleotides can be synthesized synthetically. Additionally, with the advancement of optical techniques,...